The Challenge Agricultural production has been threatened due to a significant decline in honeybees, which pollinate about 75% of major global crops. One of the largest causes of global honeybee population decline is the Varroa mite, a parasite that weakens honeybees and carries infection. The effect of this parasite can be minimized though hygienic behavior,…
News & Events
Could genetic tests help parents better understand their child’s autism?
September 18, 2015
The end of cochlear implants?
September 18, 2015
Researchers using big data to find feed-efficient dairy cattle
September 18, 2015
Perfect genetic knowledge
September 18, 2015![Can liquid biopsies advance cancer diagnosis? [OPMN Newsletter #4]](https://oldsite.ontariogenomics.ca/wp-content/uploads/2015/09/OPMN_00.jpg)
Can liquid biopsies advance cancer diagnosis? [OPMN Newsletter #4]
September 11, 2015
More Canadians to benefit from personalized cancer treatment
August 14, 2015Personalized cancer treatment requires complex clinical laboratory testing to determine a tumour’s genetic profile. The Princess Margaret Cancer Centre, a leader in providing this testing for its patients, and LifeLabs Medical Laboratory Services have begun working together to expand this testing capacity to more Canadians. The Princess Margaret Cancer Centre (PMCC) has teamed up with…
Rising prices for new targeted therapeutics threatens their own success
August 14, 2015One cancer drug alone could wipe out Canada’s total budget of $12B for prescription drugs. Can this last? Drug companies bringing out new targeted therapies for rare disorders are asking, and getting, eye-popping prices. Examples include Kalydeco® for one type of Cystic Fibrosis, reported to cost CAD$300,000 per year, or the recently marketed Solaris® for…
Can personalized cancer care be cost-effective?
August 14, 2015A study of personalized cancer care in action found that this approach not only saved money but resulted in better outcomes. Such personalized cancer treatment is available here in Ontario. A small study by Intermountain Healthcare, in Salt Lake City, compared the costs of using personalized medicine in cancer patients with late stage, metastatic disease….